Diagnostic Clues to Human Herpesvirus 6 Encephalitis and Wernicke Encephalopathy After Pediatric Hematopoietic Cell Transplantation. (September 2015)

• Record Type: Journal Article
• Authors: Sadighi, Zsila; Sabin, Noah D.; Hayden, Randall; Stewart, Elizabeth; Pillai, Asha
• Is Part Of: Journal of child neurology. Volume 30:Number 10(2015:Sep.)
• Page Start: 1307
• Page End: 1314
• Publication Date: 2015-09
• Subjects: hematopoietic cell transplant -- central nervous system -- human herpesvirus 6 encephalitis -- Wernicke encephalopathy -- thiamine; Nervous system -- Diseases -- Periodicals; 618.928
• DOI: 10.1177/0883073814560628
• Languages: English
• ISSNs: 0883-0738

Abstract

Human herpesvirus 6 (HHV6) encephalitis and Wernicke encephalopathy are treatable yet frequently undiagnosed causes of encephalopathy in pediatric recipients of allogeneic and autologous hematopoietic cell transplantation. Here we review representative cases of both conditions to highlight specific and relevant neurologic features that prompted effective diagnosis and treatment. Two patients with confusion accompanied by seizures, memory changes, or specific visual hallucinations and HHV6 detectable by polymerase chain reaction (PCR) in cerebrospinal fluid had improvement in viral load with ganciclovir or foscarnet treatment. Two patients had confusion, ataxia, or ocular changes and low serum thiamine levels, which resolved with parenteral thiamine. In all cases, definitive diagnosis and treatment were facilitated by a high index of suspicion and search for specific pathognomonic neurologic deficits accompanying the confusional state. It is critical to clinically differentiate these 2 conditions from other common neurologic syndromes occurring after transplant, allowing potentially improved patient outcomes by prompt diagnosis and effective treatment.